Case Report
Single brain metastasis as onset of stage I endometrial carcinoma in patient affected by multiple sclerosis: the first case in literature
Marco Marinaccio*, Clark Christopher, Porfido Valeria, Carmen Zaza, Giovanni Falcicchio, Roberta Pellicciari, Maria Luigia Mastronardi, Alessia Giannoccaro, Miriam Dellino and Ettore Cicinelli
Published: 25 April, 2023 | Volume 7 - Issue 1 | Pages: 012-015
Brain metastases in any gynecological cancer are a rare occurrence. Even more so, it is extremely rare for a gynecological malignancy to manifest itself with symptoms indicative of cerebral involvement. Literature regarding the association between MS and cancer is conflicting. We herein report a rare presentation of single metastasis of endometrial carcinoma in a 59-year-old woman affected by Primary Progressive Multiple Sclerosis (PPMS). A head CT scan was performed, which revealed the presence of an expansive lesion in the left parietal region. After careful assessment, a high-grade endometrial carcinoma was diagnosed and a decision was made to remove both the primary lesion and the brain metastasis in one sitting, through a conjoined surgery session involving neurosurgeons and gynecologists. The postoperative course was free from complications up until a few days after being transferred to a rehabilitation center, where she died following respiratory complications.
Read Full Article HTML
DOI: 10.29328/journal.ascr.1001068
Cite this Article
Read Full Article PDF
Keywords:
Brain metastasis; Endometrial cancer; Multiple sclerosis
References
- Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø. Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. Mult Scler. 2020 Oct;26(12):1569-1580. doi: 10.1177/1352458519877244. Epub 2019 Oct 1. PMID: 31573834.
- Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Sorensen PS, Reingold SC, Cutter G. A systematic review of the incidence and prevalence of cancer in multiple sclerosis. Mult Scler. 2015 Mar;21(3):294-304. doi: 10.1177/1352458514564489. Epub 2014 Dec 22. PMID: 25533302; PMCID: PMC4429168.
- Hacker NF, Rao A. Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review. Gynecol Oncol Res Pract. 2016 Jun 17;3:7. doi: 10.1186/s40661-016-0028-3. PMID: 27330821; PMCID: PMC4912748.
- Zhang Y, Grant MS, Stepp WH, Clark LH. Clinical characteristics of CNS metastases from primary gynecologic cancers. Gynecol Oncol Rep. 2019 Nov 11;30:100518. doi: 10.1016/j.gore.2019.100518. PMID: 31867433; PMCID: PMC6906733.
- Piura E, Piura B. Brain metastases from endometrial carcinoma. ISRN Oncol. 2012;2012:581749. doi: 10.5402/2012/581749. Epub 2012 Mar 18. PMID: 22523707; PMCID: PMC3316970.
- Confavreux C, Saddier P, Grimaud J, Moreau T, Adeleine P, Aimard G. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology. 1996 Jun;46(6):1607-12. doi: 10.1212/wnl.46.6.1607. PMID: 8649558.
- Pasternak B, Svanström H, Schmiegelow K, Jess T, Hviid A. Use of azathioprine and the risk of cancer in inflammatory bowel disease. Am J Epidemiol. 2013 Jun 1;177(11):1296-305. doi: 10.1093/aje/kws375. Epub 2013 Mar 20. PMID: 23514635.
- Kamphuis WW, Derada Troletti C, Reijerkerk A, Romero IA, de Vries HE. The blood-brain barrier in multiple sclerosis: microRNAs as key regulators. CNS Neurol Disord Drug Targets. 2015;14(2):157-67. doi: 10.2174/1871527314666150116125246. PMID: 25613507.
- Melamed E, Lee MW. Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies. Front Immunol. 2020 Jan 10;10:2954. doi: 10.3389/fimmu.2019.02954. PMID: 31998289; PMCID: PMC6965059.
- Hongell K, Kurki S, Sumelahti ML, Soilu-Hänninen M. Risk of cancer among Finnish multiple sclerosis patients. Mult Scler Relat Disord. 2019 Oct;35:221-227. doi: 10.1016/j.msard.2019.08.005. Epub 2019 Aug 5. PMID: 31404761.
- Ragonese P, Aridon P, Vazzoler G, Mazzola MA, Lo Re V, Lo Re M, Realmuto S, Alessi S, D'Amelio M, Savettieri G, Salemi G. Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study. BMC Neurol. 2017 Aug 8;17(1):155. doi: 10.1186/s12883-017-0932-0. PMID: 28789625; PMCID: PMC5549380.
- Neumann H, Cavalié A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science. 1995 Jul 28;269(5223):549-52. doi: 10.1126/science.7624779. PMID: 7624779.
- Ortiz GG, Pacheco-Moisés FP, Macías-Islas MÁ, Flores-Alvarado LJ, Mireles-Ramírez MA, González-Renovato ED, Hernández-Navarro VE, Sánchez-López AL, Alatorre-Jiménez MA. Role of the blood-brain barrier in multiple sclerosis. Arch Med Res. 2014 Nov;45(8):687-97. doi: 10.1016/j.arcmed.2014.11.013. Epub 2014 Nov 26. PMID: 25431839.
- Wilhelm I, Molnár J, Fazakas C, Haskó J, Krizbai IA. Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci. 2013 Jan 11;14(1):1383-411. doi: 10.3390/ijms14011383. PMID: 23344048; PMCID: PMC3565326.